missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Mouse IL-1 beta Uncoated ELISA Kit with Plates
ELISA
$834.00 - $834.00
Specifications
| Accession Number | P10749 |
|---|---|
| Assay Range | 8 to 1000 pg/mL |
| Assay Sensitivity | 8 pg/mL |
| Conjugate | HRP |
| Product Type | ELISA |
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
|
88-701-3A86
|
Invitrogen™
887013A86 |
10 x 96 Tests |
Pack of 10 Each for $834.00
|
|
|||||
Description
Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol. Cleavage of pro-IL-1 beta into the active 17 kDa protein requires the activation of inflammasomes, which are multi-protein complexes that respond to pathogens, stress conditions, and other danger signals. Inflammasome activation triggers the processing of the caspase-1 precursor into its active form, which in turn cleaves pro-IL-1 beta. IL-1 beta lacks a signal sequence peptide for classical ER/Golgi pathway and is secreted alongside caspase-1 via an alternate and incompletely understood mechanism. Although IL-1 beta is most often secreted in its active form, secretion of the uncleaved protein may be detectable under some biological conditions. IL-1 beta signals through two receptors, IL-1RI and IL-1RII, both of which are shared with IL-1 alpha. IL-1 beta activity can be moderated by IL-1 Receptor Antagonist (IL-1RA), a protein produced by many cell types that blocks receptor binding through competitive inhibition. IL-1 beta play an important role in innate host defense by triggering the production of other proinflammatory cytokines in target cells and initiating acute-phase responses to infection and injury. Elevated levels of IL-1 beta have been associated with many chronic inflammatory conditions IL-1 beta neutralizing antibodies potential therapeutic value.Specifications
| P10749 | |
| 8 pg/mL | |
| ELISA | |
| Colorimetric Microplate Reader | |
| IL1B | |
| HRP | |
| Cell Lysate 100 μL, Plasma 100 μL, Serum 100 μL, Supernatant 100 μL | |
| IL-1 beta | |
| 24 hrs 30 mins |
| 8 to 1000 pg/mL | |
| HRP | |
| Cell Lysates, Plasma, Serum, Supernatant | |
| 16176 | |
| Capture Antibody: Pre-titrated, purified antibody, Detection Antibody: Pre-titrated, HRP-conjugated antibody, Standard: Recombinant protein for generating standard curve and calibrating samples, 10X Coating Buffer: Buffer for plating the Capture Antibody, 5X ELISA/ELISPOT Diluent: Buffer for blocking and diluting the Detection Antibody and Enzyme, Substrate: 1X TMB Solution, Certificate of Analysis: Lot-specific instructions for dilution of antibodies and standards, 96 Well Plate: High affinity 96-well plate (included with product Cat. Nos. ending in suffixes -22, -76, -86) | |
| RUO | |
| 2°C to 8°C | |
| 1 hrs 45 mins |